Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms | 33 | 2024 | 22389 | 0.800 |
Why?
|
Genomics | 32 | 2024 | 5928 | 0.770 |
Why?
|
Lung Neoplasms | 21 | 2024 | 13594 | 0.740 |
Why?
|
Mutation | 47 | 2025 | 30266 | 0.690 |
Why?
|
DNA Copy Number Variations | 18 | 2024 | 2055 | 0.630 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 12 | 2024 | 5434 | 0.600 |
Why?
|
Carcinosarcoma | 1 | 2017 | 108 | 0.520 |
Why?
|
Aneuploidy | 6 | 2023 | 573 | 0.520 |
Why?
|
Gene Expression Regulation, Neoplastic | 22 | 2024 | 8664 | 0.510 |
Why?
|
Epigenomics | 3 | 2021 | 961 | 0.470 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2133 | 0.450 |
Why?
|
Genome, Human | 11 | 2021 | 4456 | 0.400 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 2 | 2021 | 20 | 0.360 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 10 | 2023 | 1769 | 0.350 |
Why?
|
Glioma | 6 | 2025 | 3532 | 0.340 |
Why?
|
DNA Methylation | 15 | 2021 | 4432 | 0.330 |
Why?
|
Endometrial Neoplasms | 5 | 2018 | 1386 | 0.320 |
Why?
|
High-Throughput Nucleotide Sequencing | 9 | 2024 | 3671 | 0.310 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1424 | 0.300 |
Why?
|
Loss of Heterozygosity | 5 | 2023 | 663 | 0.290 |
Why?
|
Breast Neoplasms, Male | 2 | 2020 | 212 | 0.290 |
Why?
|
PPAR gamma | 2 | 2022 | 487 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2020 | 567 | 0.280 |
Why?
|
Germ Cells | 2 | 2022 | 644 | 0.260 |
Why?
|
MicroRNAs | 10 | 2021 | 3811 | 0.250 |
Why?
|
Oncogenes | 6 | 2023 | 1236 | 0.240 |
Why?
|
Cloning, Molecular | 1 | 2010 | 4168 | 0.240 |
Why?
|
Proto-Oncogene Proteins | 7 | 2023 | 4528 | 0.240 |
Why?
|
Databases, Genetic | 7 | 2021 | 1758 | 0.230 |
Why?
|
Cell Line, Tumor | 16 | 2022 | 17173 | 0.230 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2025 | 958 | 0.230 |
Why?
|
Angiopoietin-2 | 1 | 2025 | 186 | 0.220 |
Why?
|
Cholangiocarcinoma | 2 | 2021 | 562 | 0.220 |
Why?
|
Humans | 107 | 2025 | 768970 | 0.220 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2021 | 4064 | 0.220 |
Why?
|
Bile Duct Neoplasms | 2 | 2021 | 615 | 0.220 |
Why?
|
Tumor Suppressor Proteins | 7 | 2020 | 2812 | 0.220 |
Why?
|
Brain Neoplasms | 6 | 2025 | 9213 | 0.220 |
Why?
|
Protein Kinase Inhibitors | 6 | 2024 | 5707 | 0.210 |
Why?
|
Tumor Suppressor Protein p53 | 6 | 2019 | 2960 | 0.210 |
Why?
|
NF-E2-Related Factor 2 | 4 | 2024 | 379 | 0.210 |
Why?
|
RNA, Transfer, Leu | 1 | 2022 | 13 | 0.210 |
Why?
|
Colorectal Neoplasms | 4 | 2025 | 6982 | 0.210 |
Why?
|
Software | 3 | 2022 | 4479 | 0.210 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2018 | 755 | 0.200 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2018 | 489 | 0.200 |
Why?
|
Pyridazines | 2 | 2021 | 203 | 0.200 |
Why?
|
Interferons | 2 | 2024 | 720 | 0.200 |
Why?
|
Ovarian Neoplasms | 4 | 2025 | 4919 | 0.200 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2021 | 213 | 0.200 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 4 | 2020 | 906 | 0.190 |
Why?
|
Prognosis | 16 | 2025 | 30046 | 0.190 |
Why?
|
Molecular Targeted Therapy | 7 | 2024 | 2830 | 0.190 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2018 | 2884 | 0.190 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5342 | 0.190 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1756 | 0.190 |
Why?
|
Genes, Essential | 2 | 2020 | 185 | 0.190 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2021 | 95 | 0.190 |
Why?
|
Alkylating Agents | 1 | 2021 | 132 | 0.180 |
Why?
|
Tachykinins | 1 | 2021 | 77 | 0.180 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2021 | 2893 | 0.170 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 286 | 0.170 |
Why?
|
DNA Polymerase II | 2 | 2018 | 104 | 0.170 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 149 | 0.170 |
Why?
|
Germ-Line Mutation | 4 | 2023 | 1887 | 0.170 |
Why?
|
Genetics, Population | 2 | 2021 | 944 | 0.160 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2020 | 195 | 0.160 |
Why?
|
Breast Neoplasms | 8 | 2024 | 21188 | 0.160 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2023 | 2848 | 0.160 |
Why?
|
Nuclear Proteins | 8 | 2021 | 5804 | 0.160 |
Why?
|
Gene Amplification | 5 | 2024 | 1099 | 0.160 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2018 | 640 | 0.160 |
Why?
|
Genes, Tumor Suppressor | 2 | 2023 | 1064 | 0.150 |
Why?
|
Chromatin | 4 | 2024 | 2981 | 0.150 |
Why?
|
Exons | 3 | 2020 | 2395 | 0.150 |
Why?
|
RNA-Binding Proteins | 4 | 2020 | 1891 | 0.150 |
Why?
|
Transcription Factors, TFII | 1 | 2018 | 62 | 0.150 |
Why?
|
eIF-2 Kinase | 1 | 2018 | 147 | 0.150 |
Why?
|
ras Proteins | 3 | 2018 | 1058 | 0.150 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2018 | 121 | 0.150 |
Why?
|
Adipocytes | 4 | 2005 | 1199 | 0.150 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 53 | 0.150 |
Why?
|
Signal Transduction | 16 | 2018 | 23653 | 0.150 |
Why?
|
bcl-X Protein | 1 | 2019 | 412 | 0.150 |
Why?
|
Genome | 3 | 2021 | 1754 | 0.140 |
Why?
|
Chromosomal Instability | 1 | 2018 | 176 | 0.140 |
Why?
|
Osteosarcoma | 1 | 2023 | 911 | 0.140 |
Why?
|
Genes, myc | 1 | 2018 | 391 | 0.140 |
Why?
|
Metabolic Networks and Pathways | 2 | 2018 | 800 | 0.140 |
Why?
|
Adenosine Deaminase | 1 | 2018 | 253 | 0.130 |
Why?
|
Gene Expression | 3 | 2022 | 7603 | 0.130 |
Why?
|
Thymoma | 1 | 2018 | 191 | 0.130 |
Why?
|
Transforming Growth Factor beta | 3 | 2018 | 2004 | 0.130 |
Why?
|
BRCA1 Protein | 2 | 2023 | 1156 | 0.130 |
Why?
|
RNA, Messenger | 6 | 2022 | 12806 | 0.130 |
Why?
|
Gene Expression Profiling | 8 | 2022 | 9549 | 0.130 |
Why?
|
Phosphoproteins | 3 | 2017 | 2452 | 0.130 |
Why?
|
Pancreatic Neoplasms | 3 | 2023 | 5443 | 0.130 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2017 | 237 | 0.130 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4300 | 0.130 |
Why?
|
Telomerase | 3 | 2016 | 753 | 0.130 |
Why?
|
Proteins | 6 | 2013 | 6011 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 362 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1141 | 0.130 |
Why?
|
Female | 44 | 2025 | 397515 | 0.130 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2017 | 306 | 0.130 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 308 | 0.130 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2542 | 0.130 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2021 | 1629 | 0.120 |
Why?
|
Endometrial Hyperplasia | 1 | 2016 | 102 | 0.120 |
Why?
|
Adrenocortical Carcinoma | 1 | 2016 | 88 | 0.120 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3952 | 0.120 |
Why?
|
Cadherins | 2 | 2017 | 906 | 0.120 |
Why?
|
Thymus Neoplasms | 1 | 2018 | 277 | 0.120 |
Why?
|
Glioblastoma | 3 | 2024 | 3525 | 0.120 |
Why?
|
Central Nervous System Neoplasms | 1 | 2023 | 930 | 0.120 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2017 | 2251 | 0.120 |
Why?
|
Interleukin-13 | 1 | 2017 | 391 | 0.120 |
Why?
|
Abdominal Neoplasms | 1 | 2016 | 287 | 0.120 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 507 | 0.120 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2016 | 161 | 0.120 |
Why?
|
Gene Regulatory Networks | 3 | 2018 | 1752 | 0.120 |
Why?
|
COS Cells | 2 | 2010 | 1135 | 0.120 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2020 | 304 | 0.110 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 250 | 0.110 |
Why?
|
Genomic Instability | 1 | 2018 | 715 | 0.110 |
Why?
|
Uveal Neoplasms | 1 | 2017 | 344 | 0.110 |
Why?
|
Gene Deletion | 6 | 2020 | 2674 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2019 | 1151 | 0.110 |
Why?
|
Models, Genetic | 2 | 2021 | 3449 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 7 | 2020 | 18068 | 0.110 |
Why?
|
Enhancer Elements, Genetic | 2 | 2021 | 1369 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 5 | 2005 | 2911 | 0.110 |
Why?
|
Pleural Neoplasms | 1 | 2018 | 612 | 0.110 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 496 | 0.110 |
Why?
|
Middle Aged | 27 | 2025 | 223737 | 0.100 |
Why?
|
Meningioma | 1 | 2022 | 1226 | 0.100 |
Why?
|
Genes, p53 | 1 | 2015 | 716 | 0.100 |
Why?
|
Gene Targeting | 1 | 2016 | 841 | 0.100 |
Why?
|
Genital Neoplasms, Female | 1 | 2018 | 538 | 0.100 |
Why?
|
Receptor, erbB-2 | 5 | 2024 | 2606 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 1258 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1616 | 0.100 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1994 | 492 | 0.100 |
Why?
|
Aged | 23 | 2025 | 171786 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 998 | 0.100 |
Why?
|
Cluster Analysis | 5 | 2018 | 2732 | 0.100 |
Why?
|
Carcinoma, Renal Cell | 2 | 2020 | 3200 | 0.100 |
Why?
|
Mesothelioma | 1 | 2018 | 811 | 0.100 |
Why?
|
Retinol-Binding Proteins, Cellular | 1 | 2011 | 12 | 0.100 |
Why?
|
Apoptosis | 4 | 2022 | 9527 | 0.100 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2013 | 199 | 0.100 |
Why?
|
Testicular Neoplasms | 1 | 2018 | 808 | 0.100 |
Why?
|
Gene Dosage | 1 | 2016 | 1222 | 0.100 |
Why?
|
Aged, 80 and over | 13 | 2024 | 59739 | 0.100 |
Why?
|
3T3 Cells | 5 | 2005 | 1085 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2022 | 9442 | 0.090 |
Why?
|
Ubiquitin Thiolesterase | 3 | 2020 | 465 | 0.090 |
Why?
|
Carcinoma, Lobular | 1 | 2015 | 480 | 0.090 |
Why?
|
Protein Binding | 6 | 2021 | 9344 | 0.090 |
Why?
|
Adenocarcinoma | 3 | 2018 | 6401 | 0.090 |
Why?
|
Adult | 23 | 2025 | 223851 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2020 | 3608 | 0.090 |
Why?
|
RNA Splicing | 3 | 2019 | 905 | 0.090 |
Why?
|
Transcription Factors | 9 | 2021 | 12174 | 0.090 |
Why?
|
Tumor Escape | 1 | 2013 | 372 | 0.090 |
Why?
|
Male | 30 | 2025 | 365203 | 0.090 |
Why?
|
Bone Neoplasms | 1 | 2023 | 2565 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 620 | 0.090 |
Why?
|
Ligands | 3 | 2022 | 3283 | 0.090 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2018 | 957 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 793 | 0.090 |
Why?
|
Cell Proliferation | 7 | 2021 | 10486 | 0.090 |
Why?
|
Mice | 17 | 2024 | 82072 | 0.090 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1169 | 0.090 |
Why?
|
Age of Onset | 1 | 2017 | 3346 | 0.080 |
Why?
|
Membrane Proteins | 5 | 1996 | 7885 | 0.080 |
Why?
|
DNA, Neoplasm | 1 | 2015 | 1748 | 0.080 |
Why?
|
DNA Helicases | 3 | 2021 | 854 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 5 | 2020 | 6547 | 0.080 |
Why?
|
Phosphorylation | 7 | 2018 | 8317 | 0.080 |
Why?
|
Son of Sevenless Proteins | 5 | 1996 | 27 | 0.080 |
Why?
|
Molecular Sequence Data | 5 | 2014 | 17629 | 0.080 |
Why?
|
Young Adult | 12 | 2025 | 60131 | 0.080 |
Why?
|
Tuberous Sclerosis | 1 | 2017 | 1042 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2020 | 3621 | 0.080 |
Why?
|
Proteomics | 3 | 2022 | 3914 | 0.080 |
Why?
|
Antineoplastic Agents | 5 | 2019 | 13698 | 0.080 |
Why?
|
Chromosome Deletion | 3 | 2020 | 1390 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 4 | 2025 | 3744 | 0.080 |
Why?
|
DNA-Binding Proteins | 7 | 2020 | 9618 | 0.080 |
Why?
|
DNA Damage | 4 | 2020 | 2472 | 0.080 |
Why?
|
Peptides, Cyclic | 1 | 2010 | 391 | 0.080 |
Why?
|
Catalytic Domain | 2 | 2021 | 699 | 0.080 |
Why?
|
Promoter Regions, Genetic | 5 | 2018 | 5801 | 0.070 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2010 | 761 | 0.070 |
Why?
|
Recombinant Proteins | 3 | 2021 | 6512 | 0.070 |
Why?
|
Chromosome Aberrations | 3 | 2023 | 1780 | 0.070 |
Why?
|
Chromosomes | 2 | 2023 | 578 | 0.070 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1894 | 0.070 |
Why?
|
Retinoblastoma Protein | 1 | 2011 | 673 | 0.070 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1495 | 0.070 |
Why?
|
Lysosomes | 1 | 2013 | 940 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11262 | 0.070 |
Why?
|
Platelet-Derived Growth Factor | 3 | 2000 | 617 | 0.070 |
Why?
|
Gene Frequency | 3 | 2020 | 3626 | 0.070 |
Why?
|
Cell Line | 6 | 2013 | 15604 | 0.070 |
Why?
|
Base Sequence | 4 | 2022 | 12430 | 0.070 |
Why?
|
DNA Mutational Analysis | 4 | 2020 | 4124 | 0.070 |
Why?
|
Nanoparticles | 1 | 2019 | 1989 | 0.070 |
Why?
|
Amino Acids | 1 | 2013 | 1716 | 0.070 |
Why?
|
BRCA2 Protein | 2 | 2023 | 803 | 0.070 |
Why?
|
Animals | 20 | 2024 | 169335 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2023 | 2433 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2017 | 1483 | 0.070 |
Why?
|
Genes, Neoplasm | 2 | 2018 | 371 | 0.070 |
Why?
|
Gene Knockout Techniques | 2 | 2021 | 808 | 0.070 |
Why?
|
Peptides | 1 | 2018 | 4353 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2010 | 13427 | 0.060 |
Why?
|
Cell Death | 2 | 2022 | 1682 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 1731 | 0.060 |
Why?
|
DNA Repair | 3 | 2020 | 2054 | 0.060 |
Why?
|
Survival Rate | 4 | 2025 | 12873 | 0.060 |
Why?
|
Adolescent | 10 | 2025 | 89244 | 0.060 |
Why?
|
Immunoblotting | 2 | 2000 | 1647 | 0.060 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2020 | 701 | 0.060 |
Why?
|
Drosophila melanogaster | 1 | 1994 | 1726 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2021 | 4290 | 0.060 |
Why?
|
Angiopoietin-1 | 1 | 2025 | 134 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2931 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2020 | 2063 | 0.060 |
Why?
|
Microsatellite Instability | 2 | 2018 | 726 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2025 | 11886 | 0.060 |
Why?
|
Exoribonucleases | 1 | 2024 | 88 | 0.060 |
Why?
|
Telomere | 2 | 2023 | 943 | 0.060 |
Why?
|
Histone Demethylases | 2 | 2020 | 328 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2005 | 501 | 0.050 |
Why?
|
Protein Kinases | 2 | 2024 | 1611 | 0.050 |
Why?
|
GRB2 Adaptor Protein | 4 | 1996 | 101 | 0.050 |
Why?
|
Mutagenesis | 2 | 2020 | 1229 | 0.050 |
Why?
|
Adenosine Monophosphate | 2 | 2021 | 232 | 0.050 |
Why?
|
Kinetics | 3 | 2021 | 6332 | 0.050 |
Why?
|
Cell Cycle Proteins | 3 | 2021 | 3450 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2018 | 16053 | 0.050 |
Why?
|
Centromere | 1 | 2023 | 214 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9264 | 0.050 |
Why?
|
CpG Islands | 2 | 2018 | 1210 | 0.050 |
Why?
|
Mice, Nude | 2 | 2019 | 3631 | 0.050 |
Why?
|
Histones | 3 | 2019 | 2603 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2059 | 0.050 |
Why?
|
PTEN Phosphohydrolase | 2 | 2020 | 1120 | 0.050 |
Why?
|
Interferon-beta | 1 | 2024 | 349 | 0.050 |
Why?
|
Child | 7 | 2025 | 80960 | 0.050 |
Why?
|
Sequence Analysis, DNA | 3 | 2020 | 4785 | 0.050 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2021 | 98 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2023 | 2592 | 0.050 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2023 | 453 | 0.050 |
Why?
|
Tyrosine-tRNA Ligase | 1 | 2001 | 10 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 2044 | 0.050 |
Why?
|
Neurospora crassa | 1 | 2001 | 27 | 0.050 |
Why?
|
Tyrosine | 3 | 2001 | 1427 | 0.050 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2001 | 94 | 0.050 |
Why?
|
Tetrahydroisoquinolines | 1 | 2021 | 81 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 2 | 2010 | 8144 | 0.050 |
Why?
|
Transfection | 3 | 2000 | 5763 | 0.050 |
Why?
|
Phenotype | 4 | 2021 | 16731 | 0.050 |
Why?
|
ADP-Ribosylation Factors | 1 | 2001 | 132 | 0.050 |
Why?
|
Sucrose | 1 | 2021 | 157 | 0.040 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2000 | 558 | 0.040 |
Why?
|
Receptor, Insulin | 2 | 1995 | 838 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2041 | 0.040 |
Why?
|
Precipitin Tests | 1 | 2000 | 816 | 0.040 |
Why?
|
Receptors, Estrogen | 2 | 2018 | 2252 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2013 | 4939 | 0.040 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2020 | 98 | 0.040 |
Why?
|
src Homology Domains | 1 | 2000 | 361 | 0.040 |
Why?
|
Guanosine Triphosphate | 3 | 1995 | 315 | 0.040 |
Why?
|
DNA Primase | 1 | 2020 | 110 | 0.040 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2001 | 437 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2001 | 2749 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2025 | 39394 | 0.040 |
Why?
|
Endoribonucleases | 1 | 2021 | 231 | 0.040 |
Why?
|
Succinate Dehydrogenase | 1 | 2020 | 148 | 0.040 |
Why?
|
RNA Helicases | 1 | 2020 | 144 | 0.040 |
Why?
|
Bone Morphogenetic Protein 5 | 1 | 2018 | 5 | 0.040 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2020 | 370 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6232 | 0.040 |
Why?
|
Protein Methyltransferases | 1 | 2018 | 54 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2024 | 1866 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Melanoma | 1 | 2017 | 5709 | 0.040 |
Why?
|
Mitochondria | 2 | 2017 | 3682 | 0.040 |
Why?
|
Th1-Th2 Balance | 1 | 2018 | 38 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7453 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2020 | 534 | 0.040 |
Why?
|
Introns | 1 | 2001 | 969 | 0.040 |
Why?
|
Epigenesis, Genetic | 3 | 2018 | 3836 | 0.040 |
Why?
|
Smad Proteins | 1 | 2018 | 157 | 0.040 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2018 | 69 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2019 | 331 | 0.040 |
Why?
|
Asthma | 1 | 2017 | 6293 | 0.040 |
Why?
|
Gene Library | 1 | 2000 | 1062 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2020 | 393 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2021 | 665 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 2 | 2014 | 205 | 0.040 |
Why?
|
Eukaryotic Initiation Factor-1 | 1 | 2017 | 31 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 785 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 96 | 0.040 |
Why?
|
Karyopherins | 1 | 2018 | 134 | 0.040 |
Why?
|
Monosomy | 1 | 2017 | 52 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2019 | 400 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2022 | 1074 | 0.040 |
Why?
|
SOX9 Transcription Factor | 1 | 2018 | 146 | 0.040 |
Why?
|
G1 Phase | 1 | 2018 | 403 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2000 | 1990 | 0.040 |
Why?
|
Prospective Studies | 4 | 2025 | 54962 | 0.040 |
Why?
|
Seminoma | 1 | 2018 | 136 | 0.030 |
Why?
|
Cryoelectron Microscopy | 1 | 2021 | 649 | 0.030 |
Why?
|
Protein Structure, Tertiary | 2 | 2001 | 3775 | 0.030 |
Why?
|
Mammary Glands, Animal | 1 | 2018 | 273 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2018 | 323 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6856 | 0.030 |
Why?
|
Cohort Studies | 4 | 2022 | 41808 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 432 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2019 | 527 | 0.030 |
Why?
|
Insulin | 4 | 2001 | 6610 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3433 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3810 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 233 | 0.030 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2019 | 547 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2018 | 228 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2021 | 968 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 618 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4926 | 0.030 |
Why?
|
DNA Cleavage | 1 | 2016 | 56 | 0.030 |
Why?
|
Epidermal Growth Factor | 2 | 1996 | 697 | 0.030 |
Why?
|
Nanomedicine | 1 | 2019 | 292 | 0.030 |
Why?
|
Rats | 2 | 2010 | 23786 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2001 | 1165 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2000 | 1714 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2013 | 10276 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 1439 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2474 | 0.030 |
Why?
|
Antigens, CD | 2 | 2017 | 4032 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2015 | 130 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2022 | 2094 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 325 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mos | 1 | 2014 | 17 | 0.030 |
Why?
|
Phosphorus Radioisotopes | 1 | 1995 | 100 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2015 | 6086 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3076 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2015 | 165 | 0.030 |
Why?
|
Republic of Korea | 1 | 2017 | 592 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1625 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 560 | 0.030 |
Why?
|
Survival Analysis | 2 | 2017 | 10115 | 0.030 |
Why?
|
Documentation | 1 | 2021 | 917 | 0.030 |
Why?
|
Frozen Sections | 1 | 2015 | 154 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2020 | 1252 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2014 | 93 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 755 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2015 | 513 | 0.030 |
Why?
|
Hemagglutinins, Viral | 1 | 1994 | 66 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2018 | 725 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 245 | 0.030 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 1994 | 34 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1105 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1336 | 0.030 |
Why?
|
Cell Lineage | 1 | 2023 | 2576 | 0.030 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2013 | 42 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2015 | 350 | 0.030 |
Why?
|
Insect Hormones | 1 | 1994 | 74 | 0.030 |
Why?
|
Receptor, trkB | 1 | 2014 | 124 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2204 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2018 | 725 | 0.030 |
Why?
|
Actins | 1 | 2001 | 2065 | 0.030 |
Why?
|
Receptor, trkA | 1 | 2014 | 159 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1320 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2017 | 931 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 260 | 0.030 |
Why?
|
E1A-Associated p300 Protein | 1 | 2013 | 125 | 0.030 |
Why?
|
Cisplatin | 1 | 2019 | 1661 | 0.030 |
Why?
|
Organ Specificity | 1 | 2018 | 1970 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2025 | 81903 | 0.030 |
Why?
|
Ploidies | 1 | 2013 | 287 | 0.030 |
Why?
|
Heterozygote | 1 | 2020 | 2798 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2024 | 26428 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1340 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2015 | 751 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2013 | 314 | 0.030 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1994 | 164 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2014 | 438 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2013 | 328 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 13091 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2408 | 0.020 |
Why?
|
Repressor Proteins | 2 | 2018 | 2986 | 0.020 |
Why?
|
F-Box Proteins | 1 | 2013 | 201 | 0.020 |
Why?
|
Databases, Factual | 2 | 2018 | 8094 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 478 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12562 | 0.020 |
Why?
|
Paclitaxel | 1 | 2019 | 1735 | 0.020 |
Why?
|
Cell Membrane | 1 | 2001 | 3659 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1143 | 0.020 |
Why?
|
Estrogens | 1 | 2018 | 1536 | 0.020 |
Why?
|
Virus Integration | 1 | 2013 | 307 | 0.020 |
Why?
|
Gene Silencing | 1 | 2018 | 1505 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3629 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11116 | 0.020 |
Why?
|
Cell Survival | 1 | 2021 | 5793 | 0.020 |
Why?
|
Urinary Bladder | 1 | 2017 | 1162 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6131 | 0.020 |
Why?
|
Infant | 2 | 2024 | 36556 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2019 | 2574 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 942 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42683 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 469 | 0.020 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 1994 | 572 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 669 | 0.020 |
Why?
|
Substrate Specificity | 1 | 1994 | 1751 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2460 | 0.020 |
Why?
|
Cell Cycle | 1 | 2018 | 2937 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3163 | 0.020 |
Why?
|
DNA Primers | 1 | 1994 | 2827 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2018 | 2885 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2014 | 872 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6901 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2525 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22296 | 0.020 |
Why?
|
Methylation | 1 | 2011 | 1078 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2843 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2001 | 19023 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8055 | 0.020 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2015 | 1093 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 2001 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2025 | 65480 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2013 | 1140 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 1994 | 2003 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2018 | 4251 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7609 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1111 | 0.020 |
Why?
|
Wound Healing | 1 | 2018 | 2815 | 0.020 |
Why?
|
Cell Movement | 1 | 2019 | 5216 | 0.020 |
Why?
|
Antibodies | 1 | 1995 | 2422 | 0.020 |
Why?
|
Enzyme Inhibitors | 2 | 2011 | 3726 | 0.020 |
Why?
|
Time Factors | 2 | 2015 | 40261 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4651 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2631 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3562 | 0.020 |
Why?
|
Carcinoma | 1 | 2017 | 2340 | 0.020 |
Why?
|
Tumor Burden | 1 | 2011 | 1913 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5404 | 0.020 |
Why?
|
Quinazolines | 1 | 2011 | 1373 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10765 | 0.010 |
Why?
|
DNA | 1 | 2018 | 7214 | 0.010 |
Why?
|
Citric Acid Cycle | 1 | 2005 | 234 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 1902 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2748 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3713 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8513 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 13048 | 0.010 |
Why?
|
Risk Assessment | 1 | 2025 | 24333 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10633 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2000 | 11684 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5801 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12467 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 5505 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 14201 | 0.010 |
Why?
|
Nocodazole | 1 | 2001 | 95 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2013 | 1640 | 0.010 |
Why?
|
Glycolysis | 1 | 2005 | 838 | 0.010 |
Why?
|
Thiazolidines | 1 | 2001 | 70 | 0.010 |
Why?
|
Lung | 1 | 2020 | 10099 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1994 | 5151 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7578 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20245 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2001 | 241 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4363 | 0.010 |
Why?
|
Antimetabolites | 1 | 2001 | 129 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9565 | 0.010 |
Why?
|
Deoxyglucose | 1 | 2001 | 333 | 0.010 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2001 | 148 | 0.010 |
Why?
|
Electroporation | 1 | 2001 | 238 | 0.010 |
Why?
|
Endothelin-1 | 1 | 2001 | 296 | 0.010 |
Why?
|
Androstadienes | 1 | 2001 | 348 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13674 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15471 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2001 | 856 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12801 | 0.010 |
Why?
|
Adenoviridae | 1 | 2001 | 1095 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 13055 | 0.010 |
Why?
|
Receptors, Estradiol | 1 | 1996 | 18 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 14484 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1996 | 826 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22379 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2005 | 2905 | 0.010 |
Why?
|
Thiazoles | 1 | 2001 | 1542 | 0.010 |
Why?
|
Glucose | 1 | 2005 | 4352 | 0.010 |
Why?
|
Protein Conformation | 1 | 2001 | 3956 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74976 | 0.010 |
Why?
|
Phosphotransferases | 1 | 1993 | 302 | 0.010 |
Why?
|
RNA | 1 | 2001 | 2727 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1996 | 3588 | 0.010 |
Why?
|
United States | 1 | 2017 | 73186 | 0.010 |
Why?
|
Estradiol | 1 | 1996 | 1952 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36854 | 0.000 |
Why?
|